Carcinoma, Basal Cell

Oncology
3
Pipeline Programs
4
Companies
3
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
2
0
1
0
Early DiscoveryClinical DevelopmentMarket

Drug Modality Breakdown

Monoclonal Antibody
1100%
+ 3 programs with unclassified modality

Competitive Landscape

4 companies ranked by most advanced pipeline stage

OD
1 program
1
Tretinoin 0.1% cream or placeboPhase 31 trial
Active Trials
NCT00007631CompletedEst. Jul 2006
Philogen
PhilogenItaly - Monteriggioni
1 program
1
L19IL2 +L19TNFPhase 21 trial
Active Trials
NCT04362722Unknown40Est. Sep 2024
Regeneron
RegeneronTARRYTOWN, NY
1 program
1
cemiplimabPhase 2Monoclonal Antibody
Circle Pharma
Circle PharmaCA - South SF
1 program
Fast RamanN/A1 trial
Active Trials
NCT03482622Unknown600Est. Mar 2023

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Ortho DevelopmentTretinoin 0.1% cream or placebo
PhilogenL19IL2 +L19TNF
Circle PharmaFast Raman

Clinical Trials (3)

Total enrollment: 640 patients across 3 trials

NCT00007631Ortho DevelopmentTretinoin 0.1% cream or placebo

Determine the Efficacy of Topical Tretinoin Cream for the Prevention of Nonmelanoma Skin Cancer

Start: Mar 1998Est. completion: Jul 2006
Phase 3Completed
NCT04362722PhilogenL19IL2 +L19TNF

Intratumoral Administration of Daromun in Non-melanoma Skin Cancer Patients

Start: Sep 2020Est. completion: Sep 202440 patients
Phase 2Unknown

Intraoperative Detection of Residual BCC by Fast Raman

Start: Apr 2018Est. completion: Mar 2023600 patients
N/AUnknown

Related Jobs in Oncology

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 late-stage (Phase 3) programs — potential near-term approvals
4 companies competing in this space